The most common type is osteoarthritis, primarily caused by joint wear and tear. There’s also inflammatory arthritis, including psoriatic arthritis related to the inflammatory skin condition psoriasis ...
Despite keen interest in BAFF-R inhibition, rheumatologists favor BMS’ Sotyktu (deucravacitinib) as the leading therapy in development for Sjögren’s.EXTON, PA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- ...
When compared with other biologic therapies, patients with psoriasis receiving IL-23 inhibitors had a lower risk for inflammatory arthritis or psoriatic arthritis development.